The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Correlation of killer-cell Ig-like receptor (KIR) haplotypes and Fcγ-receptor polymorphisms with survival of high-risk relapsed/refractory neuroblastoma patients treated by long-term infusion of anti-GD2 antibody ch14.18/CHO.
 
Holger N. Lode
Consulting or Advisory Role - Apeiron Biologics
 
Sascha Troschke-Meurer
No Relationships to Disclose
 
Dominique Valteau-Couanet
No Relationships to Disclose
 
Alberto Garaventa
No Relationships to Disclose
 
Juliet Gray
Consulting or Advisory Role - AstraZeneca; Pfizer
 
Victoria Castel
No Relationships to Disclose
 
Isaac Yaniv
No Relationships to Disclose
 
Christian Jensen
No Relationships to Disclose
 
Christin Eger
No Relationships to Disclose
 
Madlen Juettner
No Relationships to Disclose
 
Silke Kietz
No Relationships to Disclose
 
Karoline Ehlert
No Relationships to Disclose
 
Evelyne Janzek
Employment - Apeiron Biologics
Stock and Other Ownership Interests - Apeiron Biologics
Honoraria - Apeiron Biologics
Other Relationship - Apeiron Biologics
 
Hans Loibner
Employment - Apeiron Biologics
Leadership - Apeiron Biologics
Stock and Other Ownership Interests - Apeiron Biologics
Honoraria - Apeiron Biologics
Consulting or Advisory Role - Apeiron Biologics
Research Funding - Apeiron Biologics
Patents, Royalties, Other Intellectual Property - Apeiron Biologics
 
Nikolai Siebert
No Relationships to Disclose
 
Ina Mueller
No Relationships to Disclose
 
Ruth Ladenstein
Consulting or Advisory Role - Apeiron Biologics